Important Dates

1. Abstract Submission Deadline: June 7, 2024, at 5:00 PM EDT
2. Disclosure Submission Deadline: June 7, 2024, at 5:00 PM EDT
3. Abstract Notifications Mailed: July 8, 2024 
4. Abstract Withdrawal Deadline: July 15, 2024, at 5:00 PM EDT
5. Abstract Presenter Discounted Registration Deadline: August 2, 2024 

Submission Portal

Access the submission portal here. 

Instructions to Submitters

The presenting author’s affiliation cannot be a pharmaceutical company. Presenting authors must register, attend, and present at the Exchange.

• Ensure all email addresses are correct.
• Revisit the site as often as necessary to complete your submission.
• Users must use one of the following browsers: Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+, MS Edge. We do not recommend Internet Explorer.
• At any point in the abstract process, the submitter of the abstract can log in to submission to view abstract details and any correspondence about submission(s).

Submission Categories 

The Exchange is looking for abstracts that highlight disruption, transformation, and innovation in value-based care in the following areas. Authors should choose the appropriate category in the online submission system:

• Clinical Decision Making: Data management, accessing, tracking, sharing, reporting; data analytics and prescriptive analytics; artificial intelligence (AI); etc.
• Clinical Operating Efficiencies: Drug supply chain; EMR interoperability; clinical trials participation; pathways development, implementation, and compliance; etc.
• Administrative and Business Management Efficiencies: Revenue cycle management & optimization; prior authorization & claims denials; alternative payment models; etc.
• Care Delivery Improvements: Quality improvement and quality reporting; patient navigation; patient advocacy; financial toxicity; social determinants of health (SDoH); access to care and barriers to access; filling gaps in the continuum of care; etc.
• Other Value-Based Care Improvements: Immunotherapy; molecular profiling/testing; early diagnosis; CAR-T outpatient treatment; etc.

Guidelines 

Participants interested in presenting data should submit abstracts online by June 21, 2024. Abstracts are subject to acceptance by the Leadership Committee. Once accepted, abstracts will be published on the Journal of Clinical Pathways website, and top-rated abstracts will be selected for Q&A sessions. Acceptance notifications and guidelines for poster presentations will be sent on July 8, 2024. Authors of accepted abstracts who have not registered will have until August 2, 2024, to do so at the early registration rate. 

Encore Abstract Submissions

The Exchange will consider encore abstract submissions if there is a substantial new information/data in the abstract. 

Abstract Guidelines

• Follow the online instructions
• Abstracts must be written in English
• All accepted abstracts will have a place in the poster hall, but only the top-rated abstracts may be considered for a Poster Discussion session where select Exchange speakers moderate a discussion on chosen posters. Authors will be notified if their abstract is selected for the poster discussion.
• The submitted work must not, and will not have been: published in any journal, or on any website before September 6, 2024, or presented at any national or international scientific conference prior to September 6, 2024.
• Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, if you say yes, you may be asked to submit the original abstract as a reference.
• Abstract body must not be longer than 500 words.
• Use a concise title. Title should be in title case (e.g., Using Food Science to Enhance STEM Education).
• List affiliations of author(s) as briefly as possible; include city, province/state, and country.
• Maximum number of authors: 10
• Use standard, commonly accepted abbreviations.
• Abstract content should be single-spaced and typed using standard capitalization/lowercase lettering.
• Abstracts shall be of original research and contain a concise statement of study aim.
• Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
• Abstract submissions can only be completed and finalized once all authors have submitted their disclosures. There is an "email author" function to allow submitters to send reminders to their co-authors to submit disclosures. The disclosure deadline is the same as the submission deadline. NO exceptions will be made to this policy. 

Changes to Abstracts

You may change your abstract even after finalizing, up until the submission deadline of June 7, 2024, at 5:00 PM EDT. Once the submission site has closed, changes to abstracts will not be accepted. 

Abstract Withdrawal

Deadline for withdrawing abstracts is July 15, 2024, at 5:00 PM EDT. The Exchange will not make any exceptions to this rule.